| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $334K | -75.5% | -49.4% |
| R&D Expense | $5.5M | -23.7% | -32.5% |
| SG&A Expense | $3.3M | -13.1% | +13.1% |
| Operating Income | -$8.4M | +12.1% | +18.6% |
| Pre-tax Income | -$8.6M | -24.8% | -168.2% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$8.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.8M | +34.3% | -48.5% |
| Short-term Investments | $23.1M | -31.5% | -42.3% |
| Current Assets | $48.7M | -13.8% | -39.5% |
| Total Assets | $51.1M | -15.9% | -48.4% |
| Current Liabilities | $8.5M | -22.0% | -67.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.7M | — | — |
| Investing Cash Flow | $36.1M | — | — |
| Financing Cash Flow | -$14.1M | — | — |
| -205.9% |
| EPS (Basic) | -$0.17 | -21.4% | -183.3% |
| EPS (Diluted) | -$0.17 | -21.4% | -183.3% |
| $14.6M |
| -9.8% |
| -63.9% |
| Stockholders' Equity | $36.4M | -18.1% | -37.8% |